Key statistics
As of last trade, Karolinska Development AB (2I9:FRA) traded at 0.0061, 6,000.00% above the 52 week low of 0.0001 set on Feb 11, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 0.0061 |
|---|---|
| High | 0.0061 |
| Low | 0.0061 |
| Bid | 0.0061 |
| Offer | 0.0562 |
| Previous close | 0.0015 |
| Average volume | 0.00 |
|---|---|
| Shares outstanding | 942.72m |
| Free float | 104.87m |
| P/E (TTM) | -- |
| Market cap | 311.10m SEK |
| EPS (TTM) | -0.4096 SEK |
Data delayed at least 15 minutes, as of Feb 16 2026 07:09 GMT.
More ▼
Announcements
- Bokslutskommuniké för januari – december 2025
- Year-end Report - January-December 2025
- KDventures AB (publ) carries out a directed issue of shares to guarantors in connection with the completed rights issue
- KDventures AB (publ) genomför riktad nyemission av aktier till garanter i samband med den genomförda företrädesemissionen
- KDventures portföljbolag SVF Vaccines utser Raheleh Nassaji till verkställande direktör
- KDventures´ portfolio company SVF Vaccines appoints Raheleh Nassaji as Chief Executive Officer
- Karolinska Development’s portfolio company SVF Vaccines and Novakand Pharma enters into a reverse acquisition agreement
- Karolinska Developments portföljbolag SVF Vaccines ingår avtal med Novakand Pharma om omvänt förvärv
- Karolinska Development AB (publ) announces the outcome of the rights issue and change of the company name to KDventures AB
- Karolinska Development AB (publ) offentliggör utfall i företrädesemissionen och genomför namnbyte till KDventures AB
More ▼
